Patent 8110209 was granted and assigned to Xeris Pharmaceuticals, Inc. on February, 2012 by the United States Patent and Trademark Office.
The delivery of biopharmaceutical and other therapeutic agents parenterally to an animal via a minimally invasive, low pain administration is provided. The agents are delivered to the patient via, e.g., the epidermal, dermal, or subcutaneous layer of the skin in a concentrated form of injectable paste of slurry.